— Know what they know.
Not Investment Advice

RTSL OTC

Rapid Therapeutic Science Laboratories, Inc.
1W: +0.0% 1M: +0.0% 3M: +300.0% YTD: -80.0% 1Y: -86.7% 3Y: -99.9% 5Y: -99.9%
$0.00
+0.00 (+0.00%)
 
OTC · Healthcare · Medical - Pharmaceuticals · Tech Score Neutral · Power 52 · $3533 mcap · 4M float · 0.0010% daily turnover · Short 70% of daily vol

Balance Sheet Trends

Total Assets
$968K +0.0% ▲
5Y CAGR: +165.1%
Total Liabilities
$4M +0.0% ▲
5Y CAGR: +166.2%
Shareholders Equity
-$3M +0.0% ▲
Cash & Investments
$0 +0.0% ▲
Total Debt
$3M +0.0% ▲
5Y CAGR: +158.3%
Net Debt
$3M +0.0% ▲

Assets vs Liabilities & Equity

Year-over-Year Growth

View Full Balance Sheet
Line ItemFY2017FY2019FY2021FY2022FY2024
— Assets —
Cash$12K$136K$192K$0$0
Short-Term Investments$0$0$0$0$0
Cash & ST Investments$12K$136K$192K$0$0
Net Receivables$0$0$0$0$0
Inventory$0$0$175K$175K$175K
Other Current Assets$10K$0$52K$0$0
Total Current Assets$22K$142K$419K$233K$175K
Property, Plant & Equip.$0$0$2M$2M$623K
Goodwill & Intangibles$4K$302K$170K$170K$170K
Long-Term Investments$0$0$0$0$0
Other Non-Current Assets$0$0$0$0$0
Total Non-Current Assets$4K$302K$2M$2M$793K
Total Assets$26K$445K$2M$2M$968K
— Liabilities —
Accounts Payable$15K$65K$465K$891K$212K
Short-Term Debt$645K$907K$1M$3M$3M
Deferred Revenue$0$32K$0$0$0
Other Current Liabilities$0$0$1M$549K$393K
Total Current Liabilities$689K$1M$3M$5M$4M
Long-Term Debt$2M$315K$150K$150K$0
Other Non-Current Liab.$0$0$0$0$0
Total Non-Current Liabilities$2M$315K$529K$430K$0
Total Liabilities$3M$2M$4M$5M$4M
— Equity —
Common Stock$1K$160K$8K$8K$19K
Retained Earnings-$3M-$4M-$9M-$10M-$10M
Accumulated OCI$0$0$0$0$0
Total Stockholders Equity-$3M-$1M-$1M-$3M-$3M
Total Liabilities & Equity$26K$445K$2M$2M$968K
— Key Metrics —
Total Debt$3M$1M$2M$4M$3M
Net Debt$3M$1M$2M$4M$3M
Total Investments$0$0$0$0$0

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms